Pharmanutra Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Pharmanutra stock has a consensus rating of "Strong Buy" and an average price target of €94.33. The average 1-year stock price forecast is 5.51% higher than the current stock price, while the lowest is €92.00 (+2.91%) and the highest is €98.00 (+9.62%).

Price Target: €94.33 (+5.51%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	€92.00	€94.33	€93.00	€98.00
Change	+2.91%	+5.51%	+4.03%	+9.62%

* Price targets were last updated on May 13, 2026.

Analyst Ratings

The average analyst rating for Pharmanutra stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Berenberg Bank No rating	Berenberg Bank	Buy Maintains €85.00 → €93.00	Buy	Maintains	€85.00 → €93.00	+4.03%	May 13, 2026
Giorgio Tavolini Intermonte	Intermonte	Buy Maintains €89.00 → €98.00	Buy	Maintains	€89.00 → €98.00	+9.62%	May 12, 2026
Corentin Marty TP ICAP MIDCAP	TP ICAP MIDCAP	Buy Reiterates €74.00	Buy	Reiterates	€74.00	-17.23%	Feb 3, 2026

Financial Forecast

Revenue This Year

155.16M

from 132.16M

17.41%

from 132.16M

Revenue Next Year

180.74M

from 155.16M

16.49%

from 155.16M

EPS This Year

2.54

from 2.09

21.58%

from 2.09

EPS Next Year

3.14

from 2.54

23.57%

from 2.54

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	68.14M	83.06M	100.71M	116.15M	132.16M	155.16M
Revenue Growth	20.04%	21.89%	21.24%	15.34%	13.78%	17.41%
Gross Profit	32.15M	41.92M	48.62M	59.24M	66.79M	148.25M
Gross Margin	47.18%	50.47%	48.28%	51.00%	50.54%	95.55%
Operating Income	18.30M	23.07M	23.02M	27.36M	29.10M	36.14M
Net Income	13.77M	15.05M	12.83M	16.61M	20.00M	24.85M
EPS	-	-	-	-	2.09	2.54
EPS Growth	-	-	-	-	20.81%	21.58%
Forward PE	53.54	38.79	32.36	25.25	23.47	35.18
Dividend / Share	0.71	0.80	0.85	1.00	1.20	1.48
Dividend Growth	-	12.68%	6.25%	17.65%	20.00%	23.03%
Free Cash Flow	11.35M	-14.67M	2.25M	12.74M	15.20M	21.54M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	156.7M
Avg	155.2M
Low	153.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	18.6%
Avg	17.4%
Low	15.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	2.54
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	21.6%
Low	-